Medpace Bioanalytical Laboratories (MBL) is continuously working with our sponsors to expand our commercially available assay lists, as well as our proprietary assay list.

For a list of current MBL assays grouped therapeutically in a printable PDF file, click here.

All of our assays are developed in a GLP environment, following either MBL SOPs or our sponsor’s SOPs depending on the requirements for the assay. All of our validated assays meet the FDA guidance for bioanalytical method validation. When developing a new assay, we build upon our senior management’s experience of over 20 years of bioanalytical method development. This allows us to develop and validate many assays in a shorter time frame than our competitors.

For large molecules, PK analysis methods and Anti-Drug antibody methods are included.

For more information on one of the assays listed, or if interested in developing a new assay, please contact us. We will be happy to discuss some of our other commercially available assays or the development of a new proprietary assay.